NEVRO CORP's ticker is and the CUSIP is 64157FAA1. A total of 22 filers reported holding NEVRO CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 115,776,000 | $168,437,000 | 3.54% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,004,000 | $4,536,000 | 0.11% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,416,000 | $9,226,000 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 8,908,000 | $12,978,000 | 0.02% |
| Citadel Advisors | 29,066,000 | $42,190,000 | 0.01% |
| BNP PARIBAS FINANCIAL MARKETS | 3,200,000 | $4,614,176,000 | 0.01% |
| PUTNAM INVESTMENTS LLC | 919,000 | $1,341,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 6,681,000 | $9,762,000 | 0.00% |
| CREDIT SUISSE AG/ | 859,000 | $1,239,000 | 0.00% |
| MORGAN STANLEY | 470,000 | $680,000 | 0.00% |